Terms: = Kidney tumors AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
52 results:
1. An In Vitro Analysis of TKI-Based Sequence Therapy in Renal Cell Carcinoma Cell Lines.
Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982721
[TBL] [Abstract] [Full Text] [Related]
2. Deregulation of SPOP in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
3. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
Khan T; Lyons NJ; Gough M; Kwah KKX; Cuda TJ; Snell CE; Tse BW; Sokolowski KA; Pearce LA; Adams TE; Rose SE; Puttick S; Pajic M; Adams MN; He Y; Hooper JD; Kryza T
Theranostics; 2022; 12(16):6915-6930. PubMed ID: 36276654
[No Abstract] [Full Text] [Related]
4. Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors.
Tahiri A; Puco K; Naji F; Kristensen VN; Alfsen GC; Farkas L; Nilsen FS; Müller S; Oldenburg J; Geisler J
Oncotarget; 2022; 13():970-981. PubMed ID: 36093296
[TBL] [Abstract] [Full Text] [Related]
5. Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
Fang Y; Ji W; Yan C
Dis Markers; 2022; 2022():1195875. PubMed ID: 36046376
[TBL] [Abstract] [Full Text] [Related]
6. src Family Kinases: A Potential Therapeutic Target for Acute kidney Injury.
Li N; Lin G; Zhang H; Sun J; Gui M; Liu Y; Li W; Liu J; Tang J
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883540
[TBL] [Abstract] [Full Text] [Related]
7. Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.
Wu Z; Peng Y; Xiong L; Wang J; Li Z; Ning K; Deng M; Wang N; Wei W; Li Z; Dong P; Yu C; Zhou F; Zhang Z
Cancer Med; 2022 Oct; 11(19):3674-3686. PubMed ID: 35476809
[TBL] [Abstract] [Full Text] [Related]
8. Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.
Lue HW; Derrick DS; Rao S; Van Gaest A; Cheng L; Podolak J; Lawson S; Xue C; Garg D; White R; Ryan CW; Drake JM; Ritz A; Heiser LM; Thomas GV
Cell Rep Med; 2021 May; 2(5):100267. PubMed ID: 34095877
[TBL] [Abstract] [Full Text] [Related]
9. The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
10. Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice.
Wang J; Iannarelli R; Pucciarelli S; Laudadio E; Galeazzi R; Giangrossi M; Falconi M; Cui L; Navia AM; Buccioni M; Marucci G; Tomassoni D; Serini L; Sut S; Maggi F; Dall'Acqua S; Marchini C; Amici A
Pharmacol Res; 2020 Nov; 161():105123. PubMed ID: 32822867
[TBL] [Abstract] [Full Text] [Related]
11. Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation?
Liu B; Wang Y; Tian S; Hertzanu Y; Zhao X; Li Y
Thorac Cancer; 2020 Mar; 11(3):697-703. PubMed ID: 31995853
[TBL] [Abstract] [Full Text] [Related]
12. BSA-bounded p-cresyl sulfate potentiates the malignancy of bladder carcinoma by triggering cell migration and EMT through the ROS/src/FAK signaling pathway.
Peng YS; Syu JP; Wang SD; Pan PC; Kung HN
Cell Biol Toxicol; 2020 Aug; 36(4):287-300. PubMed ID: 31873818
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and Complication of Flexible Ureteroscopic Holmium Laser Incision for Simple Renal Cysts: A Retrospective Study.
Shen J; Chen Y; Wang R
J Endourol; 2019 Nov; 33(11):881-886. PubMed ID: 31710258
[No Abstract] [Full Text] [Related]
14. S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma.
Xiao Y; Zhao H; Tian L; Nolley R; Diep AN; Ernst A; Fuh KC; Miao YR; von Eyben R; Leppert JT; Brooks JD; Peehl DM; Giaccia AJ; Rankin EB
Cancer Res; 2019 Nov; 79(22):5758-5768. PubMed ID: 31585940
[TBL] [Abstract] [Full Text] [Related]
15. Personalized kidney dosimetry in
Hou X; Zhao W; Beauregard JM; Celler A
Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
[TBL] [Abstract] [Full Text] [Related]
16. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the src and Akt pathway.
Ha YS; Kim YY; Yu NH; Chun SY; Choi SH; Lee JN; Kim BS; Yoo ES; Kwon TG
Investig Clin Urol; 2018 Jul; 59(4):263-274. PubMed ID: 29984342
[TBL] [Abstract] [Full Text] [Related]
17. βArrestin2 Mediates Renal Cell Carcinoma Tumor Growth.
Masannat J; Purayil HT; Zhang Y; Russin M; Mahmud I; Kim W; Liao D; Daaka Y
Sci Rep; 2018 Mar; 8(1):4879. PubMed ID: 29559707
[TBL] [Abstract] [Full Text] [Related]
18. 6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib.
Liu Y; Lou G; Norton JT; Wang C; Kandela I; Tang S; Shank NI; Gupta P; Huang M; Avram MJ; Green R; Mazar A; Appella D; Chen Z; Huang S
FASEB J; 2017 Dec; 31(12):5453-5465. PubMed ID: 28821631
[TBL] [Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas.
Roskoski R
Pharmacol Res; 2017 Jun; 120():116-132. PubMed ID: 28330784
[TBL] [Abstract] [Full Text] [Related]
20. Everolimus suppresses invasion and migration of renal cell carcinoma by inhibiting FAK activity and reversing epithelial to mesenchymal transition in vitro and in vivo.
Wu SW; Chen PN; Lin CY; Hsieh YS; Chang HR
Environ Toxicol; 2017 Jul; 32(7):1888-1898. PubMed ID: 28258630
[TBL] [Abstract] [Full Text] [Related]
[Next]
